Literature DB >> 12442662

Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?

Stephen J Kish1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12442662

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


× No keyword cloud information.
  21 in total

1.  Magnetization transfer and adiabatic R 1ρ MRI in the brainstem of Parkinson's disease.

Authors:  Paul J Tuite; Silvia Mangia; Andrew E Tyan; Michael K Lee; Michael Garwood; Shalom Michaeli
Journal:  Parkinsonism Relat Disord       Date:  2012-01-20       Impact factor: 4.891

Review 2.  The external globus pallidus: progress and perspectives.

Authors:  Daniel J Hegeman; Ellie S Hong; Vivian M Hernández; C Savio Chan
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

3.  Risk of sleep-disordered breathing in Parkinson's disease.

Authors:  Wattanachai Chotinaiwattarakul; Praveen Dayalu; Ronald D Chervin; Roger L Albin
Journal:  Sleep Breath       Date:  2010-05-16       Impact factor: 2.816

4.  Positron emission tomography neuroimaging in Parkinson's disease.

Authors:  Clare Loane; Marios Politis
Journal:  Am J Transl Res       Date:  2011-07-10       Impact factor: 4.060

Review 5.  Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Mol Neurobiol       Date:  2012-01-06       Impact factor: 5.590

6.  Separating the effect of reward from corrective feedback during learning in patients with Parkinson's disease.

Authors:  Michael Freedberg; Jonathan Schacherer; Kuan-Hua Chen; Ergun Y Uc; Nandakumar S Narayanan; Eliot Hazeltine
Journal:  Cogn Affect Behav Neurosci       Date:  2017-06       Impact factor: 3.282

Review 7.  Non-human primate models of PD to test novel therapies.

Authors:  Marc Morissette; Thérèse Di Paolo
Journal:  J Neural Transm (Vienna)       Date:  2017-04-08       Impact factor: 3.575

8.  Brain serotonin transporter in human methamphetamine users.

Authors:  Stephen J Kish; Paul S Fitzmaurice; Isabelle Boileau; Gregory A Schmunk; Lee-Cyn Ang; Yoshiaki Furukawa; Li-Jan Chang; Dennis J Wickham; Allan Sherwin; Junchao Tong
Journal:  Psychopharmacology (Berl)       Date:  2008-10-08       Impact factor: 4.530

Review 9.  Treatment of depression in Parkinson's disease.

Authors:  Matthew Menza; Roseanne DeFronzo Dobkin; Humberto Marin
Journal:  Curr Psychiatry Rep       Date:  2006-06       Impact factor: 5.285

10.  Association between 5-HTTLPR polymorphism and Parkinson's disease: a meta analysis.

Authors:  Lianbo Gao; Honghua Gao
Journal:  Mol Biol Rep       Date:  2014-06-28       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.